The therapeutic effects of GLP-1 RAslowering blood glucose and promoting weight lossare driven by interactions with G protein-coupled receptors (GPCRs) located in the pancreas, central nervous system (CNS), and peripheral tisses (Figure 1)(Zheng et al., 2024)
The serious risks (allergic reactions, liver effects) are associated mainly with high-dose, unregulated IV use, which is why medical supervision and sensible dosing matter
Patients often feel full and rarely feel hungry
You may start with the lowest dose of a GLP-1 after your first visit and gradually increase as tolerated, based on follow-up visits
It is to use physician-guided GLP-1 therapy to build a foundation, then maintain your results at the lowest effective dose possible, ideally alongside sustainable lifestyle habits that make the medication do less work over time
We conclude that a proclaimed gap in diagnostic accuracy between dermoscopy and clinical examination, as exemplified by smartphone images, is not narrowed down by use of CNN algorithms and therefore, use of a dermoscope substantially improves diagnostic accuracy with or without a CNN